Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SEC charges former NBTY counsel

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Securities & Exchange Commission filed insider trading charges against former NBTY associate general counsel Mitchell Drucker and his father Ronald Drucker March 2, the commission announces. According to the complaint filed in federal court for the southern district of New York, Mitchell Drucker sold of all his NBTY stock on Oct. 18, 2001 after learning that the firm's fourth-quarter earnings would be 50% lower than analysts had previously predicted. The information was not publicly released until the following day. Mitchell Drucker also instructed his father to sell his shares and oversaw the sale of all of a friend's shares in the firm. Mitchell and Ronald Drucker avoided losses of $138,174 and $51,116, respectively. In addition to the disgorgement of losses avoided and civil penalties, SEC also is asking that the court bar Mitchell Drucker from acting as an officer or director of a public company...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099160

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel